Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Symyx Therapeutics, which applies high-throughput techniques to biopharmaceutical discovery, has changed its name to Ilypsa. The company has also appointed Scott M. Rocklage to be executive chairman. Rocklage is a partner in 5AM Ventures and the chairman of Cubist Pharmaceuticals. Additionally, Ilypsa, which had been working out of Symyx Technologies' facilities, is moving to its own 21,000-sq-ft space in Santa Clara, Calif. Investors in Ilypsa include the Sprout Group, Symyx Technologies, and 5AM Ventures.
This article has been sent to the following recipient: